share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

SEC ·  Aug 23 06:50
Summary by Futu AI
On August 20, 2024, Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of the company's Class A Common Stock. The transaction was carried out on the open market at a price of $7.1226 per share, resulting in a total sale value of approximately $81,532.40. Following this transaction, Borgeson directly holds a total of 7,132,769 shares in Recursion Pharmaceuticals.
On August 20, 2024, Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of the company's Class A Common Stock. The transaction was carried out on the open market at a price of $7.1226 per share, resulting in a total sale value of approximately $81,532.40. Following this transaction, Borgeson directly holds a total of 7,132,769 shares in Recursion Pharmaceuticals.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated